Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Amphastar Pharmaceuticals, Inc. on June 12, 2019. The company is incorporated in Delaware and its common stock trades on the NASDAQ under the symbol AMPH. The registrant is classified as an emerging growth company.
Key Financial Metrics
This filing is a current report regarding corporate governance events and does not contain financial data. There are no disclosures regarding revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The filing details the outcomes of two proposals voted on by stockholders:
- Election of Directors: Three Class III director nominees were elected to serve until the 2022 annual meeting.
- Ratification of Auditors: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2019.
Guidance, Outlook, and Risks
This document contains no management commentary, financial guidance, outlook, risk factors, or discussion of contingencies. It strictly reports the voting results of the annual meeting.
Investor Verification Checklist
- Verify the specific vote counts for the three elected directors: Jack Yongfeng Zhang, Richard Prins, and Diane G. Gerst.
- Confirm the ratification of Ernst & Young LLP as the auditor for the 2019 fiscal year.
- Note that this filing does not provide updated financial performance; refer to the most recent 10-Q or 10-K for financial metrics.